Development of genetically engineered bacteria for production of selected aromatic compounds
US6210937A · kind A · utility
11Cited by
9References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 1998 |
| Grant date | Apr 3, 2001 |
| Priority date | — |
| Expiry date | Apr 22, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/52
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The cloning and expression of genes in the common aromatic pathway of E. coli are described. A compound for which chorismate, the final product of the common aromatic pathway, is an anabolic intermediate can be produced by cloning and expressing selected genes of the common aromatic pathway and the genes coding for enzymes necessary to convert chorismate to the selected compound. Plasmids carrying selected genes of the common aromatic pathway are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.